Cigna Group (CI)

Over the past six months, The Cigna Group's stock (CI) has experienced various movements and events. The stock price decreased over the last 12 months but has shown recent upward trends. Positive earnings reports and FDA approvals have boosted market confidence. Cigna Group reported earnings per share (EPS) surpassing analyst estimates, and Barclays revised its price target upwards. In January 2024, the company agreed to sell its Medicare Advantage, Medicare Supplemental Benefits, Medicare Part D, and CareAllies businesses to Health Care Service Corporation. A quarterly dividend was paid on September 18, 2025. Recent analyst commentary includes target prices and ratings from Robert W. Baird, Weiss Ratings, Wall Street Zen, and Wells Fargo & Company. In November 2023, Cigna terminated its merger discussions with Humana.

The demand for The Cigna Group's products and services can be influenced by the highly competitive healthcare industry and public health crises. Competitive pressures may lead to reduced prices and increased revenue sharing with clients. Public health crises, such as pandemics, can significantly shift healthcare demand and delivery, creating operational and financial challenges for the company. Demand can fluctuate based on competitive pressures and public health trends.

The Cigna Group is a global health company providing health solutions and services, operating in the Financial Services sector, specifically in Managed Healthcare and Insurance. Its core business revolves around providing comprehensive health solutions, including pharmacy benefit services, specialty and care services, and comprehensive medical plan services. The company offers medical, dental, behavioral health, disability, life, and accident insurance products through its segments, Cigna Healthcare and Evernorth Health Services. Key offerings also encompass pharmacy benefit management (PBM) through its subsidiary Express Scripts, specialty pharmacy services, home delivery pharmacy, employer-sponsored health plans, Medicare Advantage, Medicare Supplement, Medicare Part D plans, Medicaid plans, and individual and family health insurance plans.

The Cigna Group has a significant global presence, serving over 178 million customer relationships across more than 30 countries and jurisdictions. While its headquarters are in the United States, Cigna targets both the U.S. and international markets. The company has operations in locations such as Visalia, California; Greenock, Scotland; Shanghai, China; and Antwerp, Belgium, with sales offices strategically located across North America, Europe, Asia, and the Middle East.

In the past year, The Cigna Group has received positive recognition for its commitment to diversity and inclusion, ranking No. 7 on Fair360's 2024 Top 50 Companies. Cigna also exceeded its goal of spending $1 billion annually with small and diverse businesses ahead of schedule and has committed to a multiyear philanthropic initiative. However, Cigna has faced past controversies, including allegations of automatically denying insurance claims without proper review.

Institutional investors hold a significant majority of The Cigna Group's shares, ranging from approximately 76% to 89% of the company. Major institutional owners include Vanguard Group Inc., BlackRock, Inc., State Street Corp, Massachusetts Financial Services Co /ma/, Fmr Llc (Fidelity Investments), Price T Rowe Associates Inc /md/, Dodge & Cox, and Sanders Capital, LLC. Individual investors and company insiders collectively own a smaller portion, with insiders holding less than 1% of the company's shares.